サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：口蹄疫ワクチン市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年
市場調査レポート
商品コード
1301471

口蹄疫ワクチン市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年

Foot and Mouth Disease Vaccine Market (Type: Aluminum Hydroxide and Saponin Vaccines and Oil-based Vaccines; and Animal: Cattle, Sheep and Goat, Swine/Pig, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 158 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
口蹄疫ワクチン市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年
出版日: 2023年05月11日
発行: Transparency Market Research
ページ情報: 英文 158 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

口蹄疫ワクチン市場- レポートの範囲

世界の口蹄疫ワクチン市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。レポートは、世界の口蹄疫ワクチン市場の収益を提供します。 2023年を基準年、2031年を予測年として考慮した、2017年から2031年の期間の口腔疾患ワクチン市場。レポートは、2023年から2031年までの世界の口蹄疫ワクチン市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、口蹄疫ワクチン市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

このレポートは、世界の口蹄疫ワクチン市場の競合情勢を詳しく掘り下げています。世界の口蹄疫ワクチン市場で活動している主要プレーヤーが特定され、これらのそれぞれがさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の口蹄疫ワクチン市場のプレーヤーの属性です。

目次

第1章 序文

第2章 仮定と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017～2031年

第5章 重要な洞察

  • 口蹄疫の概要
  • 疾病の有病率と発生率の概要
  • 規制シナリオ
  • 主要な業界イベント
  • COVID-19パンデミックによる業界への影響（バリューチェーンと短期・中期・長期的な影響）

第6章 世界市場の分析と予測：タイプ別

  • イントロダクションと定義
  • 主な発見/開発
  • 市場金額予測：タイプ別、2017-2031
    • 水酸化アルミニウムとサポニンのワクチン
    • 石油ベースのワクチン
      • シングルオイルエマルション
      • ダブルオイルエマルジョン
  • 市場の魅力：タイプ別

第7章 世界市場の分析と予測：動物別

  • イントロダクションと定義
  • 主な発見/開発
  • 市場金額予測：動物別、2017-2031
    • 牛
    • 羊とヤギ
    • 豚・豚
    • その他
  • 市場の魅力：動物別

第8章 世界市場の分析と予測：流通チャネル別

  • イントロダクションと定義
  • 主な発見/開発
  • 市場金額予測：流通チャネル別、2017-2031
    • 動物病院
    • 政府機関
    • その他
  • 市場の魅力：流通チャネル別

第9章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
    • 世界のその他の地域
  • 市場の魅力：国・地域別

第10章 アジア太平洋市場の分析と予測

第11章 ラテンアメリカ市場の分析と予測

第12章 中東およびアフリカ市場の分析と予測

第13章 世界のその他の地域の市場分析と予測

第14章 競合情勢

  • 市場企業-競合マトリックス（企業の階層および規模別）
  • 企業プロファイル
    • BVI
    • Indian Immunologicals Ltd.
    • Ceva Sante Animale
    • MEVAC
    • National Veterinary Institute
    • Limor de Colombia SAS
    • Brilliant Bio Pharma
    • Biogenesis Bago
    • Kenya Veterinary Vaccines Production Institute
    • Boehringer Ingelheim International GmbH
    • Zoetis, Inc.
    • Ourofino Saude Animal
図表

List of Tables

  • Table 01: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031
  • Table 02: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031
  • Table 03: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031
  • Table 04: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 05: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Region, 2017-2031
  • Table 06: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031
  • Table 07: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031
  • Table 08: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031
  • Table 09: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 10: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
  • Table 11: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031
  • Table 12: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031
  • Table 13: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031
  • Table 14: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 15: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031
  • Table 17: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031
  • Table 18: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031
  • Table 19: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 20: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
  • Table 21: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031
  • Table 22: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031
  • Table 23: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031
  • Table 24: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 02: Foot and Mouth Disease Vaccine Market Value Share, by Type, 2022
  • Figure 03: Foot and Mouth Disease Vaccine Market Value Share, by Animal, 2022
  • Figure 04: Foot and Mouth Disease Vaccine Market Value Share, by Distribution Channel, 2022
  • Figure 05: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 06: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 07: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn), by Aluminum Hydroxide and Saponin Vaccines, 2017-2031
  • Figure 08: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn), by Oil-based Vaccines, 2017-2031
  • Figure 09: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031
  • Figure 10: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031
  • Figure 11: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Cattle, 2017-2031
  • Figure 12: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Sheep and Goat, 2017-2031
  • Figure 13: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Swine/Pig, 2017-2031
  • Figure 14: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Others, 2017-2031
  • Figure 15: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 16: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 17: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Veterinary Clinics, 2017-2031
  • Figure 18: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Government Institutions, 2017-2031
  • Figure 19: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Others, 2017-2031
  • Figure 20: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 21: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 22: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 23: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 24: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 25: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031
  • Figure 26: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031
  • Figure 27: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 28: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 29: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 30: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 31: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 32: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 33: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 34: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031
  • Figure 35: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031
  • Figure 36: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 37: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 38: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 39: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 40: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 41: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 42: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 43: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031
  • Figure 44: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031
  • Figure 45: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 46: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 47: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 48: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 49: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 50: Rest of the World Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 51: Rest of the World Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 52: Rest of the World Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031
  • Figure 53: Rest of the World Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031
  • Figure 54: Rest of the World Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 55: Rest of the World Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031
目次
Product Code: TMRGL2480

Foot and Mouth Disease Vaccine Market - Scope of Report

TMR's report on the global Foot and Mouth Disease Vaccine market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Foot and Mouth Disease Vaccine market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Foot and Mouth Disease Vaccine market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Foot and Mouth Disease Vaccine market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Foot and Mouth Disease Vaccine market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Foot and Mouth Disease Vaccine market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Foot and Mouth Disease Vaccine market.

The report delves into the competitive landscape of the global Foot and Mouth Disease Vaccine market. Key players operating in the global Foot and Mouth Disease Vaccine market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Foot and Mouth Disease Vaccine market profiled in this report.

Key Questions Answered in Global Foot and Mouth Disease Vaccine Market Report:

  • What is the sales/revenue generated by Foot and Mouth Disease Vaccine across all regions during the forecast period?
  • What are the opportunities in the global Foot and Mouth Disease Vaccine market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Foot and Mouth Disease Vaccine Market - Research Objectives and Research Approach

The comprehensive report on the global Foot and Mouth Disease Vaccine market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Foot and Mouth Disease Vaccine market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Foot and Mouth Disease Vaccine market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Foot and Mouth Disease Vaccine Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Foot and Mouth Disease Overview
  • 5.2. Disease Prevalence & Incidence Rate Overview
  • 5.3. Regulatory Scenario
  • 5.4. Key Industry Events
  • 5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)

6. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type, 2017-2031
    • 6.3.1. Aluminum Hydroxide and Saponin Vaccines
    • 6.3.2. Oil-based Vaccines
      • 6.3.2.1. Single-oil Emulsion
      • 6.3.2.2. Double-oil Emulsion
  • 6.4. Market Attractiveness, by Type

7. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Animal

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Animal, 2017-2031
    • 7.3.1. Cattle
    • 7.3.2. Sheep and Goat
    • 7.3.3. Swine/Pig
    • 7.3.4. Others
  • 7.4. Market Attractiveness, by Animal

8. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 8.3.1. Veterinary Clinics
    • 8.3.2. Government Institutions
    • 8.3.3. Others
  • 8.4. Market Attractiveness, by Distribution Channel

9. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. Asia Pacific
    • 9.2.2. Latin America
    • 9.2.3. Middle East & Africa
    • 9.2.4. Rest of the World
  • 9.3. Market Attractiveness, by Country/Region

10. Asia Pacific Foot and Mouth Disease Vaccine Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Type, 2017-2031
    • 10.2.1. Aluminum Hydroxide and Saponin Vaccines
    • 10.2.2. Oil-based Vaccines
      • 10.2.2.1. Single-oil Emulsion
      • 10.2.2.2. Double-oil Emulsion
  • 10.3. Market Value Forecast, by Animal, 2017-2031
    • 10.3.1. Cattle
    • 10.3.2. Sheep and Goat
    • 10.3.3. Swine/Pig
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.4.1. Veterinary Clinics
    • 10.4.2. Government Institutions
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.5.1. China
    • 10.5.2. India
    • 10.5.3. Rest of Asia Pacific
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Animal
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country/Sub-region

11. Latin America Foot and Mouth Disease Vaccine Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type, 2017-2031
    • 11.2.1. Aluminum Hydroxide and Saponin Vaccines
    • 11.2.2. Oil-based Vaccines
      • 11.2.2.1. Single-oil Emulsion
      • 11.2.2.2. Double-oil Emulsion
  • 11.3. Market Value Forecast, by Animal, 2017-2031
    • 11.3.1. Cattle
    • 11.3.2. Sheep and Goat
    • 11.3.3. Swine/Pig
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.4.1. Veterinary Clinics
    • 11.4.2. Government Institutions
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Brazil
    • 11.5.2. Argentina
    • 11.5.3. Rest of Latin America
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Animal
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Middle East & Africa Foot and Mouth Disease Vaccine Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2017-2031
    • 12.2.1. Aluminum Hydroxide and Saponin Vaccines
    • 12.2.2. Oil-based Vaccines
      • 12.2.2.1. Single-oil Emulsion
      • 12.2.2.2. Double-oil Emulsion
  • 12.3. Market Value Forecast, by Animal, 2017-2031
    • 12.3.1. Cattle
    • 12.3.2. Sheep and Goat
    • 12.3.3. Swine/Pig
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.4.1. Veterinary Clinics
    • 12.4.2. Government Institutions
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. GCC Countries
    • 12.5.2. South Africa
    • 12.5.3. Rest of Middle East & Africa
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Animal
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Rest of the World Foot and Mouth Disease Vaccine Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2017-2031
    • 13.2.1. Aluminum Hydroxide and Saponin Vaccines
    • 13.2.2. Oil-based Vaccines
      • 13.2.2.1. Single-oil Emulsion
      • 13.2.2.2. Double-oil Emulsion
  • 13.3. Market Value Forecast, by Animal, 2017-2031
    • 13.3.1. Cattle
    • 13.3.2. Sheep and Goat
    • 13.3.3. Swine/Pig
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.4.1. Veterinary Clinics
    • 13.4.2. Government Institutions
    • 13.4.3. Others
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Type
    • 13.5.2. By Animal
    • 13.5.3. By Distribution Channel

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 14.2. Company Profiles
    • 14.2.1. BVI
      • 14.2.1.1. Company Overview
      • 14.2.1.2. Financial Overview
      • 14.2.1.3. Product Portfolio
      • 14.2.1.4. Business Strategies
      • 14.2.1.5. Recent Developments
    • 14.2.2. Indian Immunologicals Ltd.
      • 14.2.2.1. Company Overview
      • 14.2.2.2. Financial Overview
      • 14.2.2.3. Product Portfolio
      • 14.2.2.4. Business Strategies
      • 14.2.2.5. Recent Developments
    • 14.2.3. Ceva Sante Animale
      • 14.2.3.1. Company Overview
      • 14.2.3.2. Financial Overview
      • 14.2.3.3. Product Portfolio
      • 14.2.3.4. Business Strategies
      • 14.2.3.5. Recent Developments
    • 14.2.4. MEVAC
      • 14.2.4.1. Company Overview
      • 14.2.4.2. Financial Overview
      • 14.2.4.3. Product Portfolio
      • 14.2.4.4. Business Strategies
      • 14.2.4.5. Recent Developments
    • 14.2.5. National Veterinary Institute
      • 14.2.5.1. Company Overview
      • 14.2.5.2. Financial Overview
      • 14.2.5.3. Product Portfolio
      • 14.2.5.4. Business Strategies
      • 14.2.5.5. Recent Developments
    • 14.2.6. Limor de Colombia SAS
      • 14.2.6.1. Company Overview
      • 14.2.6.2. Financial Overview
      • 14.2.6.3. Product Portfolio
      • 14.2.6.4. Business Strategies
      • 14.2.6.5. Recent Developments
    • 14.2.7. Brilliant Bio Pharma
      • 14.2.7.1. Company Overview
      • 14.2.7.2. Financial Overview
      • 14.2.7.3. Product Portfolio
      • 14.2.7.4. Business Strategies
      • 14.2.7.5. Recent Developments
    • 14.2.8. VETAL Animal Health Products, Inc.
      • 14.2.8.1. Company Overview
      • 14.2.8.2. Financial Overview
      • 14.2.8.3. Product Portfolio
      • 14.2.8.4. Business Strategies
      • 14.2.8.5. Recent Developments
    • 14.2.9. Biogenesis Bago
      • 14.2.9.1. Company Overview
      • 14.2.9.2. Financial Overview
      • 14.2.9.3. Product Portfolio
      • 14.2.9.4. Business Strategies
      • 14.2.9.5. Recent Developments
    • 14.2.10. Kenya Veterinary Vaccines Production Institute
      • 14.2.10.1. Company Overview
      • 14.2.10.2. Financial Overview
      • 14.2.10.3. Product Portfolio
      • 14.2.10.4. Business Strategies
      • 14.2.10.5. Recent Developments
    • 14.2.11. Boehringer Ingelheim International GmbH
      • 14.2.11.1. Company Overview
      • 14.2.11.2. Financial Overview
      • 14.2.11.3. Product Portfolio
      • 14.2.11.4. Business Strategies
      • 14.2.11.5. Recent Developments
    • 14.2.12. Zoetis, Inc.
      • 14.2.12.1. Company Overview
      • 14.2.12.2. Financial Overview
      • 14.2.12.3. Product Portfolio
      • 14.2.12.4. Business Strategies
      • 14.2.12.5. Recent Developments
    • 14.2.13. Ourofino Saude Animal
      • 14.2.13.1. Company Overview
      • 14.2.13.2. Financial Overview
      • 14.2.13.3. Product Portfolio
      • 14.2.13.4. Business Strategies
      • 14.2.13.5. Recent Developments